Endometriosis is not cancer. It is a chronic condition where tissue similar to the uterine lining grows outside the uterus, and while it shares some biological behaviors with cancer (invasion into surrounding tissue, forming its own blood supply, resisting normal cell death), it is a benign disease. That said, endometriosis does slightly raise the risk of certain ovarian cancers, and neither endometriosis itself nor the cancers it can lead to have simple “cure” stories. Here’s what you need to know about both.
Why Endometriosis Gets Confused With Cancer
The confusion is understandable. Endometriosis tissue can spread to distant sites, grow its own blood vessels, and resist the body’s normal process of clearing out damaged cells. These are hallmarks of malignant disease. At a molecular level, endometriotic lesions carry more driver mutations per cell than normal uterine lining, and their cells undergo a process that makes them more mobile and invasive. In many ways, endometriosis behaves like a slow-moving intruder.
But there is a critical difference: endometriosis tissue does not become uncontrollably malignant in the vast majority of cases. It grows, causes inflammation and pain, and can damage organs, but it stays biologically distinct from cancer. Researchers have confirmed that benign endometriosis, atypical endometriosis, and endometriosis-associated ovarian cancer each carry different genetic alterations and follow different molecular pathways. They exist on a spectrum, but most endometriosis never progresses along it.
The Actual Cancer Risk
Women with endometriosis have roughly four times the ovarian cancer risk compared to women without the condition, according to NIH research. That sounds alarming, but context matters. The lifetime risk of ovarian cancer in the general population is about 1.3%. For women with endometriosis, it rises to approximately 2.5%. That means about 97 to 98 out of every 100 women with endometriosis will never develop ovarian cancer.
The two ovarian cancer subtypes most strongly linked to endometriosis are clear cell carcinoma and endometrioid carcinoma. These are not the most common forms of ovarian cancer overall, but they are the ones that can arise directly from endometriotic tissue. The transformation appears to involve a buildup of specific genetic changes over time: mutations in genes that normally suppress tumors get silenced, while genes that drive cell growth get activated. Chronic oxidative stress from the iron-rich environment inside endometriotic cysts (endometriomas) likely accelerates this process by damaging DNA and promoting abnormal cell survival.
Can Endometriosis Itself Be Cured?
No. Endometriosis is recognized as a chronic condition that often recurs after treatment. Hormonal therapies can suppress symptoms and slow the growth of lesions, but they don’t eliminate the disease. Surgery to remove endometriotic tissue is effective and sometimes necessary, particularly when the disease is compressing the ureters or bowel, but it is not a permanent fix for most people.
One large study tracking patients after laparoscopic excision of ovarian endometriomas found that cysts recurred on ultrasound in about 12% of cases within four years, and roughly 8% of patients needed a second surgery in that same timeframe. Among those with recurrent cysts, nearly three-quarters also had returning pain. Repeated surgeries carry their own risks, including reduced ovarian function, so current management emphasizes finding the right balance between surgical and medical approaches rather than pursuing a single definitive operation.
This is why many specialists frame endometriosis management the way they would any chronic disease: the goal is long-term symptom control, preserving fertility when desired, and monitoring for complications rather than expecting a one-time cure.
When Endometriosis Does Become Cancer
In the small percentage of cases where endometriosis-associated ovarian cancer develops, there is a meaningful silver lining. These cancers tend to be caught earlier than ovarian cancers unrelated to endometriosis. In one study, 69% of endometriosis-associated ovarian cancers were diagnosed at stage I or II, compared to only 46% of ovarian cancers without an endometriosis connection. This likely happens because women with endometriosis are already being monitored with imaging and pelvic exams, and because symptoms like worsening pain may prompt earlier investigation.
Earlier detection translates to better outcomes. The same study found that endometrioid ovarian cancers associated with endometriosis had a 10-year overall survival rate of approximately 90%. For low-grade endometrioid tumors specifically, 10-year survival was 100%, though that finding was based on a small group of 12 patients. The presence of endometriosis showed a trend toward better long-term survival even after accounting for the earlier stage at diagnosis, though the difference wasn’t statistically definitive.
So while “curable” depends on the stage and subtype, endometriosis-associated ovarian cancers are among the more treatable forms of the disease, largely because they’re found sooner and tend to be lower grade.
What to Watch For
If you have endometriosis, the transition to cancer is rare, but certain changes warrant attention. A shift in your usual pain pattern, particularly if pain becomes constant rather than cyclical, or if symptoms suddenly worsen after years of stability, can signal something new. Rapid growth of an endometrioma on imaging, unexplained weight loss, or bloating that doesn’t track with your menstrual cycle are also worth reporting.
Researchers are working on ways to identify which endometriotic tissue is more likely to progress. Atypical endometriosis, a specific subtype where the cells look more abnormal under a microscope, shows higher rates of cell division and distinct molecular markers compared to typical endometriosis. A panel of three protein markers has shown promise in flagging atypical endometriosis at higher risk of progression, though this isn’t yet part of routine clinical screening.
Regular follow-up with imaging, especially if you have ovarian endometriomas, remains the most practical tool for catching problems early. The overwhelming likelihood is that your endometriosis will stay what it is: a frustrating, painful, chronic condition that is not cancer.